The Biotech Funding Model Needs a Major Overhaul

The Biotech Funding Model Needs a Major Overhaul

TLDR Biotech interview with Ali Pashazadeh, Treehill Partners CEO

The “worst investment drought in recent history” is real. Whilst private biotech companies remain in the waiting post to go public, already listed ones trade below cash in hundreds. The “conveyor belt” of financing is broken. To remain viable, the biotech ecosystem needs to evolve.

Read the full article on:

https://tldrbio.tech/p/the-biotech-funding-crisis-treehill-partners-ali-pashazadeh

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.